The prevalence of these persistent non-criteria aPL is notorious in distinct thrombotic APS (TAPS) subsets, as for instance in 10–15% of APS patients with unexplained venous thrombosis [8]. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.